Mtech Access

We’re delighted to announce that we will be exhibiting at ISPOR Europe in Barcelona over the 18th–20th November 2024. Mtech Access experts will be joined on our stand (booth 1406), by our colleagues from across Petauri, including Delta Hat Limited. Visit https://lnkd.in/egQyzqDE to learn more about our plans for ISPOR and our posters, and to arrange to meet our experts. #ISPOREurope #HEOR #Petauri #marketaccess #healtheconomics #ISPOR

🌍 Exploring routes to market at ISPOR Europe! 🌍 A key theme in our research this year is the contrasting routes to market between Europe and the US. In our poster, 'Assessing the Value of Digital Health Tools: A Comparison of Methods used by the PHTI and NICE', we provide a direct comparison of Medtech reimbursement routes in the US and UK. In this video, co-authors Kimrin Pannu (Senior Analyst – Market Access) and Helena Grant (Analyst – Market Access) offer a preview of the research. Adam Brown, PhD (Director – Consulting Services) will be presenting the poster on Tuesday 19th November from 4.00–7.00pm. If you’re attending, stop by the poster hall to chat with Adam or visit us at booth 1406 to discuss our research and connect with the team. 🔗 Learn more about our plans for ISPOR and schedule a meeting with us here: https://lnkd.in/egQyzqDE #ISPOREurope #digitalhealth #medtech #HTA #NICE #MTEP #PHTI #marketaccess

We're excited to share the research we will be presenting at ISPOR Europe later this month! In this video, Stephanie Swift (Senior Consultant – Systematic Review, Mtech Access) offers a preview of the research she and her co-authors conducted for their poster: 'The Use of Patient and Carer Perspectives and Real-World Evidence in Orphan Disease Health Technology Assessment Submissions'. Shona Lang (Director – Systematic Review, Mtech Access) will be presenting the poster on Wednesday 20th November from 9:00–11:30am. If you’re attending, stop by the poster hall to chat with Shona or visit us at booth 1406 to discuss our research and connect with the team. 🔗 Learn more about our plans for ISPOR and schedule a meeting with us here: https://lnkd.in/egQyzqDE We look forward to connecting! #ISPOREurope #realworldevidence #RWE #HTA #orphandisease #raredisease #pharma #pharmaceuticals #marketaccess

Travelling back home after a very busy day looking over the Manchester skyline. What are my initial reflections following the Mtech Access NHS Symposium 2024? Honestly, I have so many questions and aspects to unpick. But there are a few things I will keep reminding myself. To keep seeking solutions that benefit the three stakeholders: patients (you/me/our loved ones), the NHS (maybe also you/me/our loved ones), and industry (also you/me/our loved ones). Finding those collaborations, areas of mutual agreement/need, talking the same language, respect and accountability.

🌟 A warm welcome to everyone joining us today in Manchester for our 2024 transforming healthcare symposium! We’re excited to share a packed agenda with insights from speakers rich in NHS experience, ready to explore key transformations in healthcare. Attendees can access our Virtual Resource Library to: • View the agenda • Read up on our guest speakers • Download the slides • Share your feedback • See who's attending from Mtech Access • Access resources • And much more... 🔗 https://lnkd.in/e9K9DJ9w We’re confident that you’ll come away with valuable insights that will enhance your market access and NHS engagement strategies. #NHSinsights #NHSWhispers #healthcaretransformation #marketaccess #specialisedcommissioning #pharma #medtech

Did you hear about the updates to the ABPI Code of Practice, which were released in September? In case you missed it, Iain Shield (Associate Director – Market Access, Mtech Access) wrote this blog post highlighting updates to prescribing information (Clause 12) and considerations around QR codes for digital communication materials. Read the full article at: https://lnkd.in/eXZ7A94M To explore what these changes may mean for your value communication materials, email info@mtechaccess.co.uk #ABPI #marketaccesss #QRcode #valuecommunication #pharma #pharmaceuticals

Looking for an expert partner to develop your next HTA, reimbursement or formulary submission? We support reimbursement preparations and dossier submissions across major markets, including NICE, SMC, AWMSG, and NCPE in the UK and Ireland, as well as the EU JCA, CADTH/CDA-AMC in Canada, and PBAC in Australia. Learn more: https://lnkd.in/d7CZZ_xf Plus, with our Petauri colleagues, one of whom serves on the Board of Directors for the AMCP, we also bring extensive expertise to crafting AMCP dossiers and PIE decks, and supporting engagement with ICER, for the US market. Meet us at ISPOR Europe 18th–20th November to explore how we can help you achieve your reimbursement goals. Visit booth 1406 to see how Mtech Access – Powered by Petauri™ can be your trusted partner for reimbursement and HTA strategy. 💬 Let's connect – email us at info@mtechaccess.co.uk to schedule a meeting or visit https://lnkd.in/egQyzqDE #ISPOREurope #marketaccess #ISPOR #HTA #reimbursement #EUJCA #pharma #pharmaceuticals #medicaldevices

Unlock valuable NHS insights and invest in your 2025 success with our NHS Spotlight Premium and Premium Plus packages. Subscribe before 15th November to enjoy a 10% discount on all Premium and Premium Plus subscriptions. With NHS Spotlight Premium, you’ll receive: ✅ The monthly NHS Spotlight newsletter – learn more and request a sample at https://lnkd.in/eC-aDgAY ✅ The full video recording of the ‘A day in the life – Key stakeholder interviews’ featured in each monthly newsletter ✅ Four 30-minute, virtual ‘Ask the Expert’ sessions with an NHS Associate from our network, delivered exclusively for your team ✅ Eight above-brand questions – submit your questions to our experts for a quick response to your above-brand queries Upgrade to Premium Plus for: ✅ Two 2-hour, virtual NHS update sessions with NHS Associates from our network, delivered exclusively for your team ✅ One 90-minute, virtual training session. A tailored session designed to enhance your team’s understanding of the NHS environment, helping to inform strategy and improve customer engagements Email nhsspotlight@mtechaccess.co.uk to learn more and claim your discount! #NHS #marketaccess #pharma #medtech #healthcareinsights #NHSinsights

Exciting news! We are thrilled to announce that The Kinetix Group—Powered by Petauri is now Petauri MAx, a strategic payer marketing agency, and Petauri Kinect, a strategic consultancy and agency focused on health system and hospital engagement! Combining deep-rooted expertise with innovative strategies, these teams will work closely together to provide seamless services and solutions that address and overcome barriers to access across the full spectrum of managed markets, delivering a meaningful impact in the healthcare community. To learn more about these new teams and how Petauri can support your business, visit: https://lnkd.in/eyh4pjJa Here's to a future where access meets innovation! #MarketAccess #HealthSystems #IDN #Payer #Agency #Reimbursement #HealthcareInnovation #PatientOutcomes

Have you heard of the Van Westendorp method for price testing? In our recent article on 'willingness to pay', Heather Wellam (Senior Consultant – Market Access, Mtech Access) compares 5 methodologies for price testing with payers and other key stakeholders, including the Van Westendorp method. ❓ What is the Van Westendorp method? The Van Westendorp method is a pricing technique that focuses on how respondents perceive a product’s value at different price levels. In this approach, participants are asked to indicate price points that they associate with various perceptions of value: prohibitively expensive, expensive, inexpensive, and so inexpensive that it raises doubts about quality. This information helps to identify the range of prices that align with the perceived value of the product. 👍 Advantages of the Van Westendorp price testing method: This methodology is simple to conduct and has the advantage of assessing a range of price levels, linked to perceived product value, rather than simply testing one price. It is straightforward to conduct and provides valuable insights by assessing a range of price levels rather than just one. This can be particularly useful during the early stages of product development, when only a draft target product profile is available, or when there is no clear comparator. 👎 Limitations of the Van Westendorp price testing method: As respondents know they are participating in a pricing study, this awareness might artificially increase their sensitivity to price. Additionally, the concept of ‘expensive’ as perceived by respondents does not always directly translate to actual reimbursement or prescribing behaviours. If you're looking to optimise your pricing strategy and ensure your product's success in the market, Mtech Access are here to help. We specialise in price testing and analysis with payers across key global markets. Whether you're exploring the impact of different pricing models or assessing reimbursement likelihood, our experienced team can provide the insights and support needed to make informed decisions. Contact us today at info@mtechaccess.co.uk to discover how we can assist you in finding the right pricing strategy for your product. #drugpricing #pricestrategy #pharma #medtech #marketaccess #Monadicpricing